Selected article for: "additional file and admission group"

Author: Arabi, Yaseen M.; Asiri, Ayed Y.; Assiri, Abdullah M.; Aziz Jokhdar, Hani A.; Alothman, Adel; Balkhy, Hanan H.; AlJohani, Sameera; Al Harbi, Shmeylan; Kojan, Suleiman; Al Jeraisy, Majed; Deeb, Ahmad M.; Memish, Ziad A.; Ghazal, Sameeh; Al Faraj, Sarah; Al-Hameed, Fahad; AlSaedi, Asim; Mandourah, Yasser; Al Mekhlafi, Ghaleb A.; Sherbeeni, Nisreen Murad; Elzein, Fatehi Elnour; Almotairi, Abdullah; Al Bshabshe, Ali; Kharaba, Ayman; Jose, Jesna; Al Harthy, Abdulrahman; Al Sulaiman, Mohammed; Mady, Ahmed; Fowler, Robert A.; Hayden, Frederick G.; Al-Dawood, Abdulaziz; Abdelzaher, Mohamed; Bajhmom, Wail; Hussein, Mohamed A.
Title: Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-ß1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial
  • Document date: 2020_1_3
  • ID: 0cah15lg_14
    Snippet: For each group we will report the time of hospital admission to randomization and the time of randomization to the first dose received of the study drugs. We will report the received study intervention and its duration for each group, in addition to the missing or incomplete doses and protocol violations (Additional file 1: Table S2 and Table S8 )......
    Document: For each group we will report the time of hospital admission to randomization and the time of randomization to the first dose received of the study drugs. We will report the received study intervention and its duration for each group, in addition to the missing or incomplete doses and protocol violations (Additional file 1: Table S2 and Table S8 ).

    Search related documents:
    Co phrase search for related documents
    • additional file and randomization hospital admission: 1, 2
    • additional file and randomization time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • additional file and study drug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • additional file and study drug receive: 1
    • additional file and study drug receive dose: 1
    • additional file and study intervention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • group duration and hospital admission: 1, 2, 3, 4, 5, 6, 7
    • group duration and study intervention: 1, 2
    • hospital admission and randomization hospital admission: 1, 2, 3, 4, 5, 6
    • hospital admission and randomization time: 1
    • hospital admission and study drug: 1, 2, 3, 4, 5, 6, 7, 8
    • hospital admission and study drug receive: 1
    • hospital admission and study intervention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • randomization time and study drug: 1, 2, 3, 4, 5
    • randomization time and study intervention: 1